Summit Wealth & Retirement Planning, Inc. Aquestive Therapeutics, Inc. Transaction History
Summit Wealth & Retirement Planning, Inc.
- $312 Million
- Q1 2025
A detailed history of Summit Wealth & Retirement Planning, Inc. transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Summit Wealth & Retirement Planning, Inc. holds 10,000 shares of AQST stock, worth $23,800. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$23,800% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding AQST
# of Institutions
129Shares Held
44.5MCall Options Held
44.6KPut Options Held
182K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$23.4 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$13 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.07MShares$9.7 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY3.73MShares$8.87 Million0.45% of portfolio
-
Geode Capital Management, LLC Boston, MA1.7MShares$4.05 Million0.0% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $127M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...